Varying degrees of derangement in ALT among diabetic patients have been reported, with the prevalence of NAFLD being increased from 27 to 73%, correlating with the increase in HbA1c levels from 6 to 8.5% concurrently. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.